gms | German Medical Science

17. Jahreskongress für Klinische Pharmakologie

Verbund Klinische Pharmakologie in Deutschland

01. - 02. Oktober 2015, Köln

Population pharmacokinetics of iohexol in elderly people

Poster Abstract

  • corresponding author presenting/speaker Max Taubert - Department of Pharmacology, Hospital of the University of Cologne, Cologne, Germany
  • author Elke Schäffner - Department of Nephrology, Charité University Medicine, Berlin, Germany
  • author Natalie Ebert - Department of Nephrology, Charité University Medicine, Berlin, Germany
  • author Markus van der Giet - Department of Nephrology, Charité University Medicine, Berlin, Germany
  • author Peter Martus - Institute for Clinical Epidemiology and applied Biostatistics, University of Tübingen, Tübingen, Germany
  • author Olga Jakob - Institute of Biostatistics and Clinical Epidemiology, Charité University Medicine, Berlin, Germany
  • author Uwe Fuhr - Department of Pharmacology, Hospital of the University of Cologne, Cologne, Germany

17. Jahreskongress für Klinische Pharmakologie. Köln, 01.-02.10.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. Doc15vklipha18

doi: 10.3205/15vklipha18, urn:nbn:de:0183-15vklipha182

Published: September 24, 2015

© 2015 Taubert et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objectives: Despite the clinical relevance of chronic kidney disease in elderly patients few equations for estimating the glomerular filtration rate (GFR) adapted to older age exist. The most frequently used equations are based on serum creatinine levels which may lead to improper estimations in older patients due to the influence of muscle mass, dietary protein intake and the higher prevalence of chronic diseases. The aim of our study is to identify reliable predictors of glomerular filtration in elderly patients using a population pharmacokinetic model of iohexol, a substance which is solely excreted renally and therefore may be used to assess renal function.

Methods: A cross-sectional subsample of 570 participants with an age of at least 70 years (mean 78.5 years, 244 women, 137 with diabetes mellitus, 434 with arterial hypertension, 85 with myocardial infarction, 43 with stroke, 130 with cancer, 298 with a history of smoking) from the Berlin Initiative Study (BIS) was used. For each participant height (1.66 [1.43-1.92] m), weight (77 [47-136] kg), serum creatinine (0.99 [0.46-4.77] mg/dL) and cystatin C (1.15 [0.23-44.20] mg/L) measurements were obtained before intravenous application of 3235 mg iohexol (mean and range). Blood samples were drawn 10, 20, 30, 60, 90, 120, 150, 180, 240, 300 and 1400 minutes after the administration of iohexol. A population pharmacokinetic model was developed using standard approaches in NONMEM 7.3 including the evaluation of covariates by stepwise covariate modeling and visual inspection.

Results: A two-compartment pharmacokinetic model with first order elimination described the data best. The central and peripheral volume of distribution were 11.30 L (10.97 - 11.69 L) and 5.40 L (5.21 - 5.53 L) respectively, the central and intercompartmental clearance were 4.16 L/h (4.07 - 4.23 L/h) and 5.42 L/h (5.10 - 5.83 L/h) (mean population estimates and 95% CI of bootstrap statistics). The elimination clearance was mainly linked to cystatin C and creatinine serum concentrations. With increasing cystatin C and creatinine concentrations the elimination clearance decreased. Minor covariates for the elimination clearance were age, weight and sex with a decrease of -0.0076 L/h per year, an increase of 0.0084 L/h per kg body weight and an 18% higher clearance in male participants. The central volume of distribution was linked to sex, creatinine and weight with a 23% higher volume in male participants, a decreasing volume with higher serum creatinine concentrations and an increase of 0.011 L per kg body weight. The observed residual (unexplained) inter-individual variability could be reduced by 61% for the elimination clearance and 32% for the central volume of distribution.

Conclusion: The clearance of iohexol was linked to a set of laboratory and demographic parameters which may be used to improve the prediction of GFR specifically in elderly patients.